ask our doctors

Chronic Lymphocytic Leukemia

Get the facts on Chronic Lymphocytic Leukemia treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Chronic Lymphocytic Leukemia prevention, screening, research, statistics and other Chronic Lymphocytic Leukemia related topics. We answer all your qestions about Chronic Lymphocytic Leukemia.

Question: Small lymphocytic lymphoma and chronic lymphocytic leukemia? What are the differences between these two diseases? Do they always occur simultaneously? Why are they always combined like SLL/CLL, are they the same disease? Include details as much as you can please. Thank You!

Answer: They are the same disease. If it is found in the lymph nodes first ie detected clinically by a swollen lymph node and a biopsy is done then it is SLL. If it was detected by a blood test first and testing done on the blood then it is in leukemic phase thus the name leukemia and called CLL. It eventually is found in both the lymph nodes and in the blood.


Chronic Lymphocytic Leukemia News

Benzene Leukemia Lawsuit Filed Over Hazardous Workplace

InjuryBoard.com
The lawsuit claims that benzene exposure led to the development of chronic lymphocytic leukemia. The lawsuit accuses the companies of negligence, and claims that they knew their products and workplaces were hazardous to workers' health.
 

Kancera Files Patents for ROR Inhibitors

Drug Discovery & Development
The company reported previously that the active ingredients against ROR is 25 times more specific than Fludarabine, which is the most common drug used to treat chronic lymphocytic leukemia (CLL). Kancera has also reported results showing that the ...
 

Utah boxing legend Don Fullmer dies

Salt Lake Tribune
By Jay Drew West Jordan ? Told last November that he only had a month or so left to live due to the effects of a 15-year battle with chronic lymphocytic leukemia, Utah boxing legend Don Fullmer again beat the odds, making it longer than doctors ...
 

Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to ...

Sacramento Bee
... 7249.9 Brain Cancer 7259.10 Breast Cancer 7289.11 Cancer (general) 7349.12 Carcinoid 7359.13 Cervical Cancer 7379.14 Chemopreventative 7389.15 Chronic Lymphocytic Leukemia 7399.16 Chronic Myelogenous Leukemia 7409.17 Chronic Myelomonocytic Leukemia ...
 

CytRx to Present at BIO CEO & Investor Conference

MarketWatch (press release)
The Company is evaluating bafetinib in the ENABLE Phase 2 clinical trial in high-risk B-cell chronic lymphocytic leukemia (B-CLL), and plans to seek a partner for further development of bafetinib. For more information about the Company, ...
 

Genetic Engineering News

Despite Flat Budget, NIH's TRND Program Tries to Spark Interest in Rare and ...
Genetic Engineering News
 

Philadelphia Inquirer

Teva Recalls 1 Batch Of Treanda Due To Presence Of Glass In Vial
Fox Business
 

Cyclacel to Present at Upcoming Investor Conferences

MarketWatch (press release)
... is in a Phase 3 trial being conducted under a SPA with the US FDA for the front-line treatment of acute myeloid leukemia in the elderly and Phase 2 studies for myelodysplastic syndromes, lung cancer and chronic lymphocytic leukemia.
 

Another Year, Another High...

NASDAQ
A number of phase 1 and 2 studies with PCI-32765 are ongoing across a panel of B-cell malignancy disorders, including chronic lymphocytic leukemia, mantle cell lymphoma, and diffuse large B-cell lymphoma. Last December, the company presented interim ...
 

Amgen Buys Micromet For Its Leukemia Drugs: A Look a Two Other Biotech Stocks ...

SmallCap Network
Nevertheless and at the end of last year, CytRx Corporation did present positive results from its Phase II ENABLE proof-of-concept clinical trial for patients with relapsed or refractory B-cell chronic lymphocytic leukemia (B-CLL).